Mycophenolic acid (MPA) (Fig. 1 ) is a toxic metabolite produced by several Penicillium species such as P. stoloniferum (2), P. viridicatum (4), P. brevicompactum (6) , and some strains of P. roqueforti (11) . In mammals, MPA is rapidly absorbed from the digestive tract, and after conjugation it is excreted as MPA-glucuronide in the urine (15) . The acute and chronic toxicity has been described for rats (5) . In some blueveined cheeses, MPA has been reported in concentrations up to 15 mg kg-' (12) .
We have developed a thin-layer chromatographic method to separate MPA from any contaminating compounds in cheese extracts with a limit of detection of 75 pg kg-'. With this method, 32 samples of the major European blue cheeses were examined. In addition, 80 strains of P. roqueforti isolated from starter cultures, cheese, and other foods were investigated for their ability to produce MPA. With MPA-producer and -nonproducer strains, experimental blue-veined cheese was made and analyzed for MPA content. With cell culture lines of human origin, the limits of sublethal toxicity were evaluated.
MATERIALS AND METHODS
Origin and maintenance of P. roqueforti strains. The strains investigated constitute the P. roqueforti culture collection of the Institute of Microbiology of the Federal Dairy Research Center in Kiel, West Germany. The sources and data of acquisition are listed in Table 1 . The microscopic and macroscopic properties of all strains agree with the classical identification as previously reported (9) . In addition, all strains grow on the selective acetic acid-Czapek-Dox medium (9) .
Stock cultures were prepared on 2% malt extract agar (E. Merck AG, Darmstadt, West Germany; no. 5398) at pH 5.6. After incubation at 25°C for 7 days, the cultures were stored at 4 to 8°C. Conidia from 7-day-old subcultures grown at 25°C served as inocula for MPA production.
Production of reference MPA. MPA-producing P. stoloniferum D310 was obtained from P. Lafont (Le Vesinet, France). From 25 liters of 2% yeast extract-5% sucrose broth (7), 10 g of crystalline MPA (mp, 141°C) was isolated. The infrared spectrum of this material, recorded in KBr pellets, showed the characteristic absorption peaks of MPA (12) .
Production of MPA by P. roqueforti in 2% yeast extract-5% sucrose broth. For estimation of the MPAproducing potential of P. roqueforti, 0.1 ml of conidial suspension (1 x 108 to 3 x 108 conidia ml-') of each strain was added to 100 ml of liquid medium in 500-mi Erlenmeyer flasks. Incubation was for 10 (14) .
(ii) Cheese extracts. A 10-pAl amount was spotted onto silica gel plates and separated by two-dimensional chromatography (16) . As solvent systems for the first dimension, n-hexane-ethylacetate (94:6, vol/vol) followed by ethylether-n-hexane-formic acid (60:20:4, vol/vol/vol) were applied; for the second dimension, CHC13-acetone-water (93:7:1, vol/vol/vol) was used (13) .
MPA was then directly quantitated on the developed thin-layer plates, using a double-beam spectrodensitometer (Schoeffel, Westwood, N.J.), by UV remission at 250 and 300 nm, respectively (7). The identity of MPA was checked by scanning the UV spectrum of the suspected spot with the same instrument by fluorescence quenching of the fluorescence indicator of the plates and by fluorescence after spraying of the plates with ammonia (7, 11) .
Ceil culture assay for toxicity. The cell lines Detroit 98 (CCL 18, human origin) and Girardi Heart (CCL 27, human origin) were grown in Hanks medium 199 from subcultures 118 to 167 and 520 to 572, respectively. In addition, an established pig kidney cell line, AmIl (subculture 71), was used as previously described (13 jig kg-'. Figure 2 demonstrates that the twodimensional thin-layer chromatography system used allows a clear separation of MPA from contaminating UV-absorbing substances in cheese extracts. This holds true for blue-veined cheese containing MPA from the used starter culture and for cheese contaminated with isolated, crystalline MPA in vitro.
Incidence of MPA in West European blueveined cheese varieties. To confirm the work of Lafont's (11, 14) laboratory on the incidence and level of MPA in West European blue-veined cheese, we analyzed the major corresponding cheese varieties available on the German market. For this purpose, we used the above-described quantitative two-dimensional thin-layer chromatography, which allows an unequivocal separation and identification of MPA. Table 2 demonstrates that MPA was detected only in four specimens (no. 8 to 11) of roquefort cheese, which is produced from sheep's milk. These cheeses all originated from the same factory. Another roquefort cheese (no. 12) stemming from another cheese factory was free of MPA.
Potential of P. roqueforti strains to synthesize MPA. To prove that the starter culture is responsible for any MPA detectable in blue-veined cheese, we investigated the MPA-synthesizing potential of all 80 P. roqueforti strains at our disposal. Seventeen strains had been obtained from 1975 and onwards from colleagues and culture collections. The others have been isolated and identified in our own laboratory from cheeses and starter cultures. MPA production was determined in 2% yeast extract-5% sucrose broth, which gives high yields of secondary metabolites in P. roqueforti (9) . Twenty of 80 strains exhibited a significant level of MPA in broth. These strains originated mainly from other culture collections. In our own laboratory, MPA-producing strains could only be isolated from genuine roquefort cheeses of one individual cheese factory (or distributor). Strains (0.2 mg liter of broth-'). For that reason, we consider this "zero production."
Toxicity of MPA towards human cell lines. Human cell cultures have been used in our laboratory to provide a rapid screening method for the eventual mycotoxin content of food additives, especially enzymes produced by fungi (13) . In this test, cytocidal, growth inhibitory, and attachment inhibitory effects of mycotoxins may be detected. In this system, 100 ,ug of MPA ml-' had no effect on the attachment and stretching of the investigated Girardi Heart and AmIl cell lines. There was a partial reduction in the attachment rate of cells of the Detroit 98 line at this MPA concentration. After 6 days of incubation of the cell cultures in the presence of MPA, cytocidal effects were observed at >100, 33, and 4 to 11 p.g ml-' with AmII, Detroit ders. In contrast, at 50 mg kg-day-1, the monkeys were without adverse effects (5) . In rats, a moderate chronic toxicity was observed at a daily oral intake of 15 mg kg-1 (5). Large differences in the response of individual animals to MPA seem to be caused by the difference in the rate of conversion into the glucuronide form, which is easily excreted in the urine (1).
If we assume a "no effect" level for human cells at 0.5 ,ug ml-' in vitro (-0.5 mg kg-in vivo), a 70-kg human could consume 35 mg of MPA. This means a consumption of 7 kg of blueveined cheese containing 5 mg of MPA kg-1, the highest value detected in cheese on the German market. In view of the low incidence of MPA-containing cheeses on the market, the low content of MPA, and the relatively low cpnsumption of this type of cheese, no immediate toxicological risk is envisaged. In addition, starter cultures are available which produce no MPA. Tables 1 and 2 . b NT, Not tested. c ND, Not detected; limit of detection, 0.2 mg
